Deepika Slawek

Dronabinol and Epidiolex (Cannabidiol) for Uncontrolled Residual Symptoms of Buprenorphine Initiation (Demure Trial)

National Institute on Drug Abuse · R34

Contact PI · $252K · Albert Einstein College of Medicine

Improving PrEP Engagement Among Hospitalized People Who Use Substances: A Pilot Study

National Institute on Drug Abuse · R34

Contact PI · $756K · Albert Einstein College of Medicine

CARE-AI: Development of Community-Led Accountable Responsible and Ethical Recommendations for AI (CARE-AI) in HIV Implementation Science

National Institute of Allergy and Infectious Diseases · R21

Contact PI · $252K · Albert Einstein College of Medicine

The Impact of Medical Cannabis on Pain and Inflammation in People Living with HIV

National Institute on Drug Abuse · K23

Contact PI · $776.7K · Albert Einstein College of Medicine

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

Principal investigator · Not yet recruiting · Phase 3

Montefiore Medical Center

Pain Inflammation and Cannabis in HIV

Principal investigator · Completed

Montefiore Medical Center

Pain, Inflammation, and Cannabis in HIV

Principal investigator · Withdrawn

Montefiore Medical Center